supp.fit

Betaine and Folic Acid: study protocols

10 study groups took Betaine together with Folic Acid. These are the doses the studies gave. They are not a recommendation.

Betaine: what the research found →

Dose per serving from research: Betaine

10 study groups in 9 studies say how much Betaine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 60% of 10 study groups.

Daily doseStudy groups
500 mg or less
1
500 mg to 1 g
1
1 g to 2.5 g
0
2.5 g to 5 g
6
5 g to 10 g
1
over 10 g
1

Dose per serving from research: Folic Acid

10 study groups in 9 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mg to 5 mg, 50% of 10 study groups.

Daily doseStudy groups
250 mcg to 500 mcg
2
500 mcg to 1 mg
1
1 mg to 2.5 mg
0
2.5 mg to 5 mg
5
5 mg to 10 mg
0
10 mg to 25 mg
2

Commonly used together

6 of 10 study groups took Betaine and Folic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin B12
3
Vitamin B6
3

10 study groups

Study
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy
2000 · Folic acid 5 mg daily with betaine 4 g per day (12-week phase) · Adults on maintenance dialysis with end-stage renal disease and hyperhomocysteinemia
4 g5 mg12 weeks—
A study of the treatment of Rett syndrome with folate and betaine
2009 · Folate–betaine combination, participants weighing less than 30 kg · Females aged 1.2–28.9 years with Rett syndrome and a MECP2 gene mutation; participants in this dose subgroup weighed less than 30 kg
6 g15 mg1 year—
A study of the treatment of Rett syndrome with folate and betaine
2009 · Folate–betaine combination, participants weighing more than 30 kg · Females aged 1.2–28.9 years with Rett syndrome and a MECP2 gene mutation; participants in this dose subgroup weighed more than 30 kg
12 g15 mg1 year—
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
2002 · Folic acid, pyridoxine, and glycine betaine · Patients with chronic renal failure who were folate and pyridoxine replete
4 g5 mg90 days36
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
1999 · Folic acid 5 mg daily with betaine · Adults with end-stage renal disease receiving maintenance haemodialysis
4 g5 mg12 weeks—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 5 mg folic acid plus 4 g betaine (phase 1) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
4 g5 mg12 weeks—
Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy
1998 · 5 mg folic acid and 4 g betaine daily · Peritoneal dialysis patients with hyperhomocysteinemia
4 g5 mg12 weeks—
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · drink powder · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
4 g800 mcg12 weeks93
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
250 mg400 mcg60 days52
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
1 g400 mcg12 weeks44